Results 141 to 150 of about 15,946 (160)

[An analysis of clinical features in HBeAg-negative and HBeAg-positive chronic hepatitis B].

Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2010
To analyze the frequency and the clinical and virological features of HBeAg-negative and HBeAg-positive chronic hepatitis B.Four hundred and seventeen chronic hepatitis B patients, 286 males and 131 females seen in our center were studied. Liver biopsies were taken from 83 patients.The cases with HBeAg-negative chronic hepatitis B were 241 (57.8 ...
Xiao-juan, Ou, Xiao-ming, Wang, Bao-en, Wang, Tai-ling, Wang, Hong, Ma, Hong, You, Ji-dong, Jia   +6 more
openaire   +1 more source

Hepatitis B e Antigen (HBeAg)

1985
A third antigenic specificity associated with HBV infection, designated as e antigen or HBeAg, was found in the sera of some individuals with acute or chronic hepatitis as detected by immunodiffusion (51, 52, 459). The screening of HBsAg positive sera from hemodialysis patients for this antigen revealed a close correlation between the presence of e ...
openaire   +1 more source

Increased risk of HCC in HBeAg-negative indeterminate phase compared with HBeAg-negative chronic infection

Hepatology
Background and Aims: The outcomes and benefits of antiviral therapy in patients with indeterminate phase HBeAg-negative chronic hepatitis B are not well described in treatment guidelines. We examined HCC risk among these patients.
Vicki Wing-Ki Hui, Grace Lai-Hung Wong, Junlong Dai, Yee-Kit Tse, Mandy Sze-Man Lai, Jimmy Che-To Lai, Henry Lik-Yuen Chan, Vincent Wai-Sun Wong, Terry Cheuk-Fung Yip   +8 more
openaire   +1 more source

New perspectives in the treatment of HBeAg‐positive and HBeAg‐negative chronic hepatitis B†

Hepatology, 2005
Thomas Berg, Hartmut Jaeschke, Kevin Mullen, Darius Moradpour   +3 more
openaire   +2 more sources

Increase risk of HBeAg-negative chronic hepatitis B with older age at HBeAg seroconversion

2010
Background: Recent evidence suggests that delayed HBeAg seroconversion is associated with poorer outcome. We aim to determine the incidence of HBeAg-negative chronic hepatitis B (CHB) according to the age at which HBeAg seroconversion occurs. Methods: Chronic hepatitis B patients with natural HBeAg seroconversion and over 12 months follow-up after ...
Fung, JYY, Lai, CL, Wong, DKH, Yuen, JCH, Yuen, RMF   +4 more
openaire   +2 more sources

Mathematical investigation of HBeAg seroconversion

Published ...
Kadelka, Sarah, Ciupe, Stanca M.
openaire   +1 more source

Profiles of HBV DNA, ALT and HBeAG status after stopping lamivudine in patients with HBeAg seroconversion

2010
AIM: To determine the virological and biochemical relapse rates in Chinese CHB patients with lamivudine-induced HBeAg seroconversion after stopping lamivudine therapy, and to identify significant viral or biochemical factors predictive of subsequent relapse.
Wong, DKH, Yuen, JCH, Tanaka, Y, Yuen, RMF, Mizokami, M, Fung, JYY, Lai, CL   +6 more
openaire   +2 more sources

On-treatment decline in HBeAg level at week 24 predicts for HBeAg seroconversion during long-term tenofovir therapy for HBeAg-positive CHB

Journal of Hepatology, 2017
D. Wong, M. Littlejohn, L. Yuen, K. Jackson, H. Mason, A. Gaggar, K. Kitrinos, M. Subramanian, P. Marcellin, M. Buti, H. Janssen, E. Gane, J. Bayliss, V. Sozzi, D. Colledge, S. Locarnini, A. Thompson, P. Revill   +17 more
openaire   +1 more source

HBeAg

2009
openaire   +1 more source

HBeAg-Negative Chronic Hepatitis B

2011
Mamun-Al-Mahtab Mamun-Al-Mahtab, SM Akbar   +1 more
openaire   +1 more source